We demonstrate that both Metformin-induced activation of CMA and activation of CMA by overexpression of Hsc70 in the hippocampus of APP/PS1 mice can alleviate the cognitive deficits seen in this mouse model of AD, indicating that CMA activation can indeed be a viable therapeutic avenue for treatment of the AD. Here, HSPA8 is linked to Alzheimer disease.